Noscapine Hcl Vemedia (Noscapine Hydrochloride)

Noscapine Hydrochloride acts as a central cough suppressant and is indicated for conditions involving irritating cough reflexes.

• Acute cough: provides symptomatic relief of sudden, short‑term coughing episodes.
• Chronic cough: helps reduce the frequency and severity of persistent coughing.
• Cough associated with upper respiratory infections: alleviates irritation‑induced cough during common colds or flu.

• Noscapine Hydrochloride exerts a central antitussive effect by modulating neuronal activity in the medullary cough center. Although the precise receptor interaction is not fully defined, it is thought to influence sigma‑type receptors and reduce the transmission of cough‑inducing signals, thereby decreasing the cough reflex without significant analgesic or sedative properties.

Adverse reactions may occur with any antitussive medication.

Common Side Effects

• Nausea: mild stomach upset reported by some users.
• Dizziness: occasional light‑headed sensation.
• Drowsiness: transient sleepiness, especially at higher doses.
• Headache: mild to moderate headache in a minority of patients.

Serious or Rare Side Effects

• Allergic reactions: rash, itching, or anaphylaxis in rare cases.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatic dysfunction: abnormal liver enzymes or hepatitis reported infrequently.

Before using Noscapine Hcl Vemedia, consider the following safety measures.

• Use in children under 2 years: avoid unless specifically prescribed.
• Hepatic impairment: monitor liver function and adjust use if needed.
• Concomitant CNS depressants: avoid additive sedation.
• Pregnancy: safety category unknown; use only if benefit outweighs risk.
• Breastfeeding: unknown excretion; consult healthcare professional.
• Store at room temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Noscapine Hydrochloride may interact with other medicines.

Major Interactions (Avoid)

• Opioid antitussives (e.g., codeine): additive central nervous system depression.
• Alcohol: increased sedation and dizziness.
• Benzodiazepines: heightened sedative effects.
• Other CNS depressants: risk of excessive drowsiness.

Moderate Interactions (Monitor Closely)

• Selective serotonin reuptake inhibitors (SSRIs): potential for serotonin syndrome, though rare.
• Antihistamines: may enhance drowsiness.
• Antihypertensives: possible additive hypotensive effect.